centerforbiosimilars8h
Biosimilar Approvals Streamlined With Advanced Statistics Amidst Differing Regulatory Requirements
The FDA and European Medicines Agency (EMA) mandate high similarity between biosimilars and reference products, but their ...
drugdeliverybusiness4d
Data outlines need for CGM study design guidelines
A study highlighted the accuracy of three leading continuous glucose monitors (CGM), including systems from Abbott and Dexcom.
urologytimes10d
Additional NIAGARA data spotlight benefits of durvalumab plus chemo for MIBC
The pCR was 37.3% (95% CI, 33.2-41.6) in the durvalumab arm and 27.5% (95% CI, 23.8-31.6) in the comparator arm.